Dr. Paul J. Hesketh, MD

Dr. Hesketh practices at Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health.

Dr. Hesketh's NPI, 1265427181, was assigned on September 16, 2005. Dr. Hesketh graduated from University of Connecticut School of Medicine in 1978. Dr. Hesketh holds Massachusetts license 46159.

Dr. Hesketh's primary practice is Lahey Clinic, at 41 & 45 Mall Road, Burlington, MA 01803 in Middlesex County. The practice phone is (781) 744-5100.

Dr. Hesketh's primary practice is Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health. Dr. Hesketh is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Lahey Clinic. Dmand AI also links Dr. Hesketh to 1 more group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hesketh practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hesketh's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hesketh is licensed in Massachusetts.

CMS data shows 573 Medicare services from Dr. Hesketh across 4 procedure codes in 2024, for 101 Medicare patients. Medicare paid $51,176 for them.

CMS counts 101 Medicare patients who saw Dr. Hesketh in 2024. The largest group is 75 to 84, with 44 patients. 75% of them have cancer, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hesketh's median patient age at 78, with 51% women.

In 2024, Dr. Hesketh wrote 223 Medicare Part D claims for 42 patients. 83% of them were for generic drugs. CMS names the drug for 132 of them, across 8 drugs with 11 or more claims each, at $487,959 in total drug cost. In 2023, CMS named 178 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Hesketh for performance year 2024, reported through an alternative payment model (APM). Dr. Hesketh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hesketh as offering telehealth.

Dmand AI links 49 papers to Dr. Hesketh, published from 2010 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Nausea, Vomiting and Antiemetics. Dr. Hesketh has published most often in Support Care Cancer. Dr. Hesketh's most frequent co-authors are Mark G. Kris, MD, Joan H. Schiller, MD and Bryan J. Schneider, MD.

Dmand AI links Dr. Hesketh to 10 clinical trials, 6 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung and Lung Neoplasms. National Cancer Institute (NCI) sponsors the most, 9.

CMS Open Payments shows 5 general payments to Dr. Hesketh from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 67% of the total. Varian Medical Systems, Inc. paid the most, $143.

Dr. Hesketh graduated from University of Connecticut School of Medicine in 1978.